Nanoencapsulated all-<i>trans</i> retinoic acid as an adjuvant for mucosal vaccines-Reference-Cited by-同舟云学术

Nanoencapsulated all-trans retinoic acid as an adjuvant for mucosal vaccines

Published:2023-06 Issue:13 Volume:18 Page:941-944
ISSN:1743-5889
Container-title:Nanomedicine
language:en
Short-container-title:Nanomedicine

Author:

Borges Gabriel SM¹^ORCID,Lages Eduardo B²^ORCID,Goulart Gisele AC²^ORCID,Ferreira Lucas AM²^ORCID

Affiliation:

1. Departamento de Farmácia, Faculdade de Ciências Biológicas e da Saúde, Universidade Federal dos Vales do Jequitinhonha e Mucuri, Diamantina, CEP 39100-000, Minas Gerais, Brazil

2. Departamento de Produtos Farmacêuticos, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, CEP 31270–901, Minas Gerais, Brazil

Funder

Fundação de Amparo à Pesquisa do Estado de Minas Gerais

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Publisher

Future Medicine Ltd

Subject

Development,General Materials Science,Biomedical Engineering,Medicine (miscellaneous),Bioengineering

Link

https://www.futuremedicine.com/doi/pdf/10.2217/nnm-2023-0144

Reference20 articles.

1. The effects of all-trans retinoic acid on immune cells and its formulation design for vaccines

2. Parenteral Vaccination With a Tuberculosis Subunit Vaccine in Presence of Retinoic Acid Provides Early but Transient Protection to M. Tuberculosis Infection

3. Enhancement of recombinant adenovirus vaccine-induced primary but not secondary systemic and mucosal immune responses by all-trans retinoic acid

4. Retinoic acid pre-treatment down regulates V. cholerae outer membrane vesicles induced acute inflammation and enhances mucosal immunity